Published in Blood on January 01, 1983
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med (2000) 7.48
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med (1998) 5.98
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood (2001) 4.65
The removal of leukocytes and platelets from whole blood. J Lab Clin Med (1976) 3.97
An index to deoxyribonucleic acid base compositions of bacterial species. J Gen Microbiol (1966) 3.93
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med (1991) 3.03
Agreement Between Deoxyribonucleic Acid Base Composition and Taxometric Classification of Gram-Positive Cocci. J Bacteriol (1965) 2.81
Determination of DNA base compositions from melting profiles in dilute buffers. Biopolymers (1969) 2.55
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol (2002) 2.46
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol (2001) 2.30
Identification and characterisation of Bacteroides corrodens. J Med Microbiol (1970) 2.15
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol (1993) 2.02
International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol (1977) 2.01
Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol (1994) 1.90
Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun (1969) 1.78
An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta (1968) 1.76
International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol (1979) 1.71
Strain variation in Campylobacter pylori detected by numerical analysis of one-dimensional electrophoretic protein patterns. Antonie Van Leeuwenhoek (1989) 1.64
Pathogenic lactobacilli. J Med Microbiol (1973) 1.52
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant (2000) 1.48
Demonstration of cell surface antigens and their antibodies by the peroxidase-antiperoxidase method. Transplantation (1978) 1.42
Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study. Blood (1999) 1.40
Differences in rodent cage changout results. Contemp Top Lab Anim Sci (2000) 1.39
Direct evidence of the C-like form of sodium deoxyribonucleate. Proc Natl Acad Sci U S A (1973) 1.39
Two haemoglobins Q, alpha-74 (EF3) and alpha-75 (EF4) aspartic acid to histidine. Br J Haematol (1970) 1.28
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission. Leukemia (1999) 1.26
Breast retraction assessment: an objective evaluation of cosmetic results of patients treated conservatively for breast cancer. Int J Radiat Oncol Biol Phys (1985) 1.26
Corynebacterium spp in human disease. Lancet (1978) 1.25
Prolonged human cytomegalovirus viremia following bone marrow transplantation. Transplantation (1984) 1.23
Discrimination among the transcripts of the allelic human beta-globin genes beta A, beta S and beta C using oligodeoxynucleotide hybridization probes. Gene (1986) 1.20
Propagation of large numbers of T cells with natural killer cell markers. Br J Haematol (1994) 1.19
The causative organism of contagious equine metritis 1977: proposal for a new species to be known as Haemophilus equigenitalis. Equine Vet J (1978) 1.19
Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study. Biol Blood Marrow Transplant (2000) 1.17
The ortho-nitrophenol (ONPG) test and acid from lactose in Gram-negative genera. J Clin Pathol (1973) 1.16
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood (1987) 1.14
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood (1993) 1.13
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant (2001) 1.13
Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial. J Clin Oncol (1998) 1.12
Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient. J Infect (1992) 1.12
Purification and properties of pyruvate kinase in normal and in pyruvate kinase deficient human red blood cells. Biochim Biophys Acta (1971) 1.11
The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood (1991) 1.11
Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med (1980) 1.10
A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol (1990) 1.08
Haemoglobin D Iran: 2 22 glutamic acid leads to glutamine (B4). Br J Haematol (1973) 1.07
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. Ann Intern Med (1992) 1.07
Complications of abdominal operations for malignant disease. Am J Surg (1988) 1.06
Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood (1988) 1.06
Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation (1988) 1.05
Galactokinase from human erythrocytes. Methods Enzymol (1975) 1.05
Interlaboratory comparative study of the numerical analysis of one-dimensional sodium dodecyl sulphate-polyacrylamide gel electrophoretic protein patterns of Campylobacter strains. Electrophoresis (1990) 1.05
Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. J Clin Oncol (1994) 1.05
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies. Transfus Clin Biol (2001) 1.03
Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. J Infect Dis (1986) 1.03
Prophylactic fluconazole and Candida krusei infections. N Engl J Med (1992) 1.01
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. Biol Blood Marrow Transplant (2000) 1.01
Longitudinal examination of American National Adult Reading Test (AMNART) performance in dementia of the Alzheimer type (DAT): validation and correction based on degree of cognitive decline. J Clin Exp Neuropsychol (1996) 0.99
Historical markers in the development of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (1999) 0.99
Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood (1992) 0.99
Wilms' tumor: prognostic factors for patients without metastases at diagnosis: results of the National Wilms' Tumor Study. Cancer (1978) 0.97
Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. Biol Blood Marrow Transplant (2000) 0.97
Characterization of two new variants of glucose-phosphate-isomerase deficiency with hereditary nonspherocytic hemolytic anemia. J Lab Clin Med (1972) 0.97
Pseudomonas stutzeri in pathological material. J Med Microbiol (1968) 0.96
The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology (1994) 0.96
The use of a right atrial catheter in bone marrow transplantation for acute leukemia. Exp Hematol (1978) 0.96
Thalidomide as salvage therapy for chronic graft-versus-host disease. Blood (1995) 0.96
Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission? J Med Primatol (2001) 0.95
Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge. J Med Primatol (2002) 0.95
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect. Ann N Y Acad Sci (2001) 0.95
Identification and characterization of Moraxella phenylpyruvica. J Clin Pathol (1972) 0.95
Circular dichroism of DNA. Eur J Biochem (1970) 0.95
Heart rate variability in diabetes: relationship to age and duration of the disease. Diabetes Care (1985) 0.95
A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats. Br J Ophthalmol (2008) 0.94
Pulmonary lymphomas and other pulmonary lymphoid lesions. A clinicopathologic and immunologic study of 64 patients. Cancer (1985) 0.94
Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation (1987) 0.93
Arm lymphedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique. Int J Radiat Oncol Biol Phys (1986) 0.93
Breast edema in patients treated conservatively for stage I and II breast cancer. Int J Radiat Oncol Biol Phys (1985) 0.92
Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology (1994) 0.92
Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia. Leukemia (1990) 0.92
Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biol Blood Marrow Transplant (1999) 0.92
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2001) 0.91
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. Biol Blood Marrow Transplant (2001) 0.91
Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood (1987) 0.90
Bone marrow transplantation. Part II--autologous. West J Med (1990) 0.90
The malignancy of dementia. Predictors of mortality in clinically diagnosed dementia in a population survey of Shanghai, China. Arch Neurol (1994) 0.90
Hyperplastic and neoplastic lesions of the mammary gland in macaques. Vet Pathol (2006) 0.89
Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior. Cancer (1987) 0.89
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant (2000) 0.89
Atypical lymphoplasmacytic and immunoblastic proliferation in lymph nodes of patients with autoimmune disease (autoimmune-disease-associated lymphadenopathy). Medicine (Baltimore) (1984) 0.89
LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoprotein. Proc Natl Acad Sci U S A (1988) 0.89
Abnormal haemoglobins in Iran. Observation of a new variant--haemoglobin J Iran (alpha-2-beta-2 77 His--Asp). Br Med J (1967) 0.88
Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation (1988) 0.88
Bone marrow transplantation. Part I--Allogeneic. West J Med (1989) 0.88
Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies. J Clin Oncol (1997) 0.88
Purification and properties of galactokinase from human red blood cells. J Biol Chem (1971) 0.88
Bone marrow transplantation as the treatment of choice for "good risk" adult patients with acute leukemia. Trans Assoc Am Physicians (1979) 0.88
Patient self-evaluation of cosmetic outcome of breast-preserving cancer treatment. Int J Radiat Oncol Biol Phys (1985) 0.88
LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia (2008) 0.88
Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine (Baltimore) (1996) 0.88